Your Messages Inbox
Your Article Summary
See Latest ArticlesBiovail Announces U.S. Availability of Aplenzin(TM) Tablets
BioVail Corporation, 04/08/09
Biovail Corporation announced that Aplenzin extended-release tablets are now available by prescription in the United States for adults ages 18 and older. Aplenzin, which was developed by Biovail, offers prescribers and their patients the benefit of convenience with simple one-tablet, once-daily dosing of bupropion at all doses.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor